Cooper Companies Inc (COO) Declares Semiannual Dividend of $0.03

Cooper Companies Inc (NYSE:COO) announced a semiannual dividend on Tuesday, January 8th, Wall Street Journal reports. Investors of record on Tuesday, January 22nd will be paid a dividend of 0.03 per share by the medical device company on Friday, February 8th. This represents a dividend yield of 0.02%. The ex-dividend date of this dividend is Friday, January 18th.

Cooper Companies has a dividend payout ratio of 0.5% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Cooper Companies to earn $13.13 per share next year, which means the company should continue to be able to cover its $0.06 annual dividend with an expected future payout ratio of 0.5%.

Shares of NYSE:COO opened at $253.83 on Wednesday. The company has a quick ratio of 1.16, a current ratio of 2.03 and a debt-to-equity ratio of 0.60. Cooper Companies has a fifty-two week low of $216.47 and a fifty-two week high of $283.18. The stock has a market cap of $12.12 billion, a P/E ratio of 22.07, a price-to-earnings-growth ratio of 1.94 and a beta of 0.83.



Cooper Companies (NYSE:COO) last announced its quarterly earnings data on Thursday, December 6th. The medical device company reported $2.87 earnings per share for the quarter, missing analysts’ consensus estimates of $2.96 by ($0.09). Cooper Companies had a net margin of 5.52% and a return on equity of 17.70%. The business had revenue of $651.50 million for the quarter, compared to the consensus estimate of $645.25 million. During the same period in the prior year, the company earned $2.65 EPS. Cooper Companies’s quarterly revenue was up 16.0% on a year-over-year basis. On average, equities analysts expect that Cooper Companies will post 11.54 earnings per share for the current fiscal year.

A number of equities research analysts recently weighed in on the stock. KeyCorp reaffirmed a “buy” rating on shares of Cooper Companies in a research report on Sunday, December 9th. Zacks Investment Research upgraded shares of Cooper Companies from a “sell” rating to a “hold” rating in a research report on Monday, October 1st. BMO Capital Markets upped their target price on shares of Cooper Companies from $294.00 to $306.00 and gave the stock an “outperform” rating in a research report on Friday, December 7th. Goldman Sachs Group cut shares of Cooper Companies from a “neutral” rating to a “sell” rating and decreased their target price for the stock from $233.00 to $221.00 in a research report on Friday, January 4th. Finally, Wells Fargo & Co upped their target price on shares of Cooper Companies from $290.00 to $295.00 and gave the stock an “outperform” rating in a research report on Monday, November 12th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $285.56.

In other news, Director Allan E. Rubenstein bought 348 shares of the firm’s stock in a transaction on Monday, December 10th. The stock was purchased at an average price of $241.59 per share, for a total transaction of $84,073.32. Following the transaction, the director now owns 4,524 shares in the company, valued at $1,092,953.16. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.60% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION WARNING: This piece of content was originally published by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The correct version of this piece of content can be accessed at https://dakotafinancialnews.com/2019/01/09/cooper-companies-inc-coo-declares-semiannual-dividend-of-0-03.html.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Featured Story: Using the New Google Finance Tool

Dividend History for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply